Skip to main content

Europe’s Brand New Tech Giant Doesn’t Even Have a Name Yet

European-listed tech giants are so scarce they are set to be trumped in size by a newcomer that hasn't decided what to call itself yet.

African conglomerate Naspers Ltd. revealed this week that it plans to list a portfolio that includes a range of tech investments, from food delivery to online platforms for second-hand goods. The new Amsterdam-based company will also hold a massive $133 billion stake in Chinese game-maker Tencent Holdings Ltd.

By comparison, the largest tech company in Europe, at least by market value, is German software firm SAP SE, at about 124 billion euros ($139 billion). Next on the current list is ASML Holding NV, the Dutch semiconductor manufacturer, at 69 billion euros.

While not a straight comparison, the fair value for the new Naspers listing could still be about $150 billion, according to Renaissance Capital analyst David Ferguson.

Still lacking an official name — currently called NewCo — Naspers' spin-off will be unlike any company that European investors have had access to before, at least in terms of scale.

But putting a market value on NewCo will be down to investors. One of the motives for listing in Amsterdam was to try and correct the current discount to the value of its assets. Naspers is valued at around 1.42 trillion rand ($100 billion), far below the value of its stake in Tencent.

The NewCo will also have a $1.35 billion stake in DeliveryHero. In January this year it took full control of Russian classifieds business Avito BB, buying the last 29 percent for $1.1 billion, giving its company a value of about $3.8 billion. It's 28 percent stake in Mail.Ru Group Ltd. is also worth about $1.4 billion.

While set to be listed in Amsterdam, its current outlook is to invest predominantly outside of Europe, in fast growing technology in markets such as India, Brazil and Russia. The company expects to attract European investors in terms of its “scarcity value,” said a spokeswoman Shamiela Letsoalo. “In the European context, no such group exists. Its will be a consumer internet play with exposure to several high growth markets."

The new company's products are regularly used by a fifth of the world's population, the parent company Naspers said in an investor presentation. Cape-Town based Naspers is the eight-biggest consumer internet business in the world, behind other well-known names such as Amazon.com Inc., Alphabet Inc. and Facebook Inc.

The name for this new European tech play should be expected in due course, said the company. A listing will only be done during the second half of 2019.



from Fortune https://ift.tt/2FKYDBs
Labels:

Comments

Post a Comment

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $
Post a Comment
Read more

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be
Post a Comment
Read more